Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial (2022) |
Auteurs : | Rafet Sonmez ; Necmettin Yildiz ; Hakan Alkan |
Type de document : | Article |
Dans : | Annals of Physical and Rehabilitation Medicine (Vol. 65, n° 1, January 2022) |
Article en page(s) : | 7 p. |
Note générale : | https://doi.org/10.1016/j.rehab.2021.101486 |
Langues: | Français |
Descripteurs : |
HE Vinci Essais cliniques comme sujet ; Femmes ; Nerf tibial ; Vessie urinaire |
Mots-clés: | Stimulation percutanée et transcutanée du nerf tibial ; Hyperactivité vésicale idiopathique |
Résumé : | Background Different studies have reported the efficacy of percutaneous tibial nerve stimulation (PTNS) and transcutaneous tibial nerve stimulation (TTNS) in treating idiopathic overactive bladder (OAB). However, no study has compared the effectiveness of PTNS and TTNS added to bladder training (BT) in idiopathic OAB. Objective To compare the efficacy of PTNS and TTNS added to BT in women with idiopathic OAB. Methods We randomised 60 women with idiopathic OAB into 3 groups. Group 1 (n=19) received BT, Group 2 (n=19) received PTNS in addition to BT, and Group 3 (n=20) received TTNS in addition to BT. PTNS and TTNS were performed 2 days a week, for 30min a day, for a total of 12 sessions for 6 weeks. Patients were evaluated by incontinence severity (pad test), a 3-day voiding diary (frequency of voiding, incontinence episodes, nocturia and number of pads used), symptom severity, quality of life, treatment success (positive response rate), treatment satisfaction (Likert scale), discomfort level and preparation time for stimulation (sec). Results At the end of treatment; severity of incontinence, frequency of voiding, incontinence episodes, nocturia, number of pads used, symptom severity and quality of life were significantly improved in Groups 2 and 3 versus Group 1 (P |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S187706572100004X |